Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Triton has signed an agreement to acquire SKF Motion Technologies

Stockholm (Sweden), Gothenburg (Sweden) 31 July 2018 – Funds advised by Triton (“Triton”) have signed an agreement of its intention to acquire the business unit SKF Motion Technologies from SKF Group, listed on Nasdaq Stockholm. Triton intends to form a standalone company under a new brand.Regulatory approvals, finalization of necessary consultations and other customary closing conditions are underway. SKF’s French linear and actuation technology business is dealt with on a separate process, but both parties have the intention to reach an agreement to also divest it to Triton. SKF Motion

Aker BP acquires licence portfolio from Total

Aker BP has entered into an agreement with Total E&P Norge to acquire its interests in a portfolio of 11 licences on the Norwegian Continental Shelf for a cash consideration of USD 205 million. The portfolio includes four discoveries with net recoverable resources of 83 million barrels oil equivalents ("mmboe"), based on estimates from the Norwegian Petroleum Directorate. Two of the discoveries, Trell and Trine, are located near the Aker BP-operated Alvheim field and are expected to be produced through the Alvheim FPSO. The Alve Nord discovery is located north of the Aker BP-operated

Number of shares and votes in Calliditas Therapeutics

During July, the number of shares and votes in Calliditas Therapeutics AB (publ) (the “Company”) has increased due to the issue of 1,970,000 new shares that the Company carried out pursuant to the utilization of the over-allotment option that the Company granted in order to cover any over-allotment in the offering of shares in connection with the listing of the Company’s shares on Nasdaq Stockholm. As of July 31, 2018, the number of shares and votes in the Company is 35,202,347.For further information, please contact: Renée Aguiar-Lucander, CEO at Calliditas Email: renee.lucander@

DDM Holding AG: Q2 and half year report January - June 2018

Significant increase of collections from portfoliosHighlights second quarter 2018 · Net collections increased by 55% to EUR 15.5M (Q2 2017: EUR 10.0M) · Cash EBITDA increased by 53% and amounted to EUR 13.8M (Q2 2017: EUR 9.0M) · Net profit for the period of EUR 1.0M (Q2 2017: profit of EUR 0.7M) · Gross ERC at the end of June 2018 was EUR 269M, an increase of 209% (Q2 2017: EUR 87M) · Investments in the Czech Republic and the Balkans totaling approximately EUR 6M Highlights six months 2018 · Net collections increased by 45% to EUR 26.2M (H1 2017: EUR 18.1M) ·

Essity restructures in France

To further strengthen competitiveness and increase efficiency, Essity is restructuring its Consumer Tissue production in France.Essity is closing a converting facility for retail branded products in Saint-Etienne-du-Rouvray and invests in remaining integrated production facilities in France. The closure is expected during the fourth quarter of 2018. These measures are aligned with the company’s strategy to optimize the production footprint to increase cost and capital efficiency and further increase value creation in the Consumer Tissue business area. The restructuring costs are expected

Double Bond Pharmaceutical receives patent in the United States for the BeloGal® platform

Double Bond Pharmaceuticals patent application for organ-specific administration of hydrophilic cancer drug to the liver which forms the basis for the BeloGal® technology platform has been granted in the United States. Patent approval provides protection for the technology platform BeloGal® and products on the US market at least through 2035. "It is the company's first licensed patent and we are very pleased that it concerns the largest market in the world - the United States. With the patent, we have achieved an important interim goal for the commercialization of our front-line product

Increase of number of shares and votes in Hansa Medical AB (publ)

As previously announced, the general meeting of Hansa Medical AB (publ) resolved to adopt a warrant program 2015-2019 on June 2, 2015. As part of the completion of the program, 50,000 ordinary shares have been issued. The company’s registered share capital and number of outstanding shares and votes have thus increased during the month of July 2018.As of today, the total number of registered and outstanding shares of Hansa Medical amounts to 38,463,386 whereof 38,133,125 are ordinary shares and 330,261 are Class C shares. As of today, the number of votes in Hansa Medical amounts to 38,166,

DDM Debt AB: Q2 and half year report January - June 2018

Significant increase of collections from portfoliosHighlights second quarter 2018 · Net collections increased by 57% to EUR 15.4M (Q2 2017: EUR 9.8M) · Cash EBITDA increased by 67% to EUR 13.7M (Q2 2017: EUR 8.2M) · Net profit for the period of EUR 0.6M (Q2 2017: loss of EUR 0.0M) · Investments in the Czech Republic and the Balkans totaling approximately EUR 6M Highlights six months 2018   · Net collections increased by 64% to EUR 25.9M (H1 2017: EUR 15.8M) · Cash EBITDA increased by 72% to EUR 22.5M (H1 2017: EUR 13.1M) · Net profit for the period of EUR 1.5M (

Hexagon Interim Report 1 January - 30 June 2018

Second quarter 2018- Operating net sales increased by 7 per cent to 936.9 MEUR (872.0). Using fixed exchange rates and a comparable group structure (organic growth), net sales increased by 9 per cent- Operating earnings (EBIT1) increased by 11 per cent to 228.2 MEUR (205.3)- Earnings before taxes, excluding non-recurring items, amounted to 222.8 MEUR (200.0)- Net earnings, excluding non-recurring items, amounted to 182.7 MEUR (164.3)- Earnings per share, excluding non-recurring items, increased by 11 per cent to 0.50 EUR (0.45)- Operating cash flow increased by 23 per cent to

Number of shares and votes in Internationella Engelska Skolan

During July, the number of shares and votes in Internationella Engelska Skolan i Sverige Holdings II AB (publ) (“IES”) has changed as a result of the issue and repurchase of 80,000 class C shares as announced on July 2, 2018. Today, the last trading day of the month, there are in total 40,130,000 shares - whereof 40,050,000 are ordinary shares and 80,000 are class C shares - and 40,058,000 votes in IES. For more information, please contact:Johan Hähnel, IES‘s IR Manager         Tel: +46 (0)70 605 6334 e-mail: johan.hahnel@engelska.se The information in the press release is

SKF divests linear and actuation technology business

Gothenburg, 31 July 2018: SKF has signed an agreement to divest its linear and actuation technology business to Triton. The total consideration of the deal is SEK 2.75 billion, on a cash- and debt free basis and it is expected to close during the end of 2018. The divestment is subject to regulatory approvals and involves consultation with employee representative bodies. Christian Johansson, Senior Vice President and CFO, says: “Having successfully developed this as a stand-alone entity, it will now have an ownership structure that is able to invest in its continued development. The

More from the Company Monthly Newsletter July 2018

The month of July was marked by our first distribution agreement that was signed with Leib Medical Ltd. for the United Kingdom and Ireland, face-to-face meetings with potential distributors and an all-day meeting together with the General Assembly of Euro-HYP-1 in Copenhagen.QuickCool and Leib Medical Ltd. signed the first distribution agreement at the office in Lund.Leib Medical takes responsibility for launching, marketing and selling the QuickCool© SYSTEM as well as for service, maintenance and training of the same on the important Irish and British markets. With an already established

Psyonix, acclaimed video-game developer, selects Nepa for Global Brand Measurement Insights

Nepa will measure brand KPIs of Rocket League® and Psyonix sponsorships on a continuous basis in five strategic markets – US, UK, Germany, France, and Spain.July 31th, 2018 New York, NY Nepa US Inc. announces today that they have been selected by Psyonix to provide Brand & Ad Tracking research for acclaimed video-game Rocket League and Psyonix strategic partnerships. The partnership will begin immediately with a strategic brand positioning analysis for Rocket League and key competitors. Through its Consumer Science Platform, Nepa will connect continuous measurement of key metrics such

Conversion of shares

According to SCA’s articles of association, owners of Class A shares have the right to have such shares converted to Class B shares. Conversion reduces the total number of votes in the company. When such a conversion has occurred, the company is obligated by law to disclose any such changes in this manner. In July, at the request of shareholders 159 Class A shares were converted to Class B shares. The total number of votes in the company thereafter amounts to 1,283,631,537. The total number of registered shares in the company amounts to 702,342,489 of which 64,587,672 are Class A

Skanska awarded railway contract in Poland worth about PLN 132 M, about SEK 320 M

Skanska has been awarded a railway project in the south of Poland for about PLN 132 M, about SEK 320 M. Client is the Polish Railway lines. The order will be included in the order booking for Skanska Europe in the third quarter 2018.The project includes modernization of 24 kilometres of railway lines, modernization of 7 bridges and 9 platforms, renovation of 14 culverts and reconstruction of 24 kilometres of overhead power railway line on Railway 62, Charsznica - Wolbrom - Jaroszowiec Olkuski, in the south part of Poland. Construction starts in August 2018 and will be completed in

Kamux Oyj: KAMUX STRENGTHENS ITS MANAGEMENT TEAM

KAMUX CORPORATION   STOCK EXCHANGE RELEASE   31 July 2018 9:00   KAMUX STRENGTHENS ITS MANAGEMENT TEAM Kamux has appointed Mr. Ilkka Virtanen (M. Sc. Econ, born 1980) Director, Business Development and Member of the Management Team. Mr. Virtanen will be responsible for the company's strategic development projects and business development, focusing especially on new growth opportunities. Mr. Virtanen joins Kamux from Santander Consumer Finance where he currently holds the position of Commercial Director. Mr. Virtanen will start in his new position on November 1, 2018 at the

Raute Corporation - Half-Year Report January 1 - June 30, 2018

RAUTE CORPORATION HALF-YEAR REPORT JULY 31, 2018 AT 9:00 a.m.RAUTE CORPORATION - HALF-YEAR REPORT JANUARY 1-JUNE 30, 2018- The Group’s net sales, EUR 78.9 million (MEUR 71.6), increased 10% on the comparison period. Order intake was EUR 96 million (MEUR 52).- Operating profit was EUR 5.9 million (MEUR 4.0), showing growth of 48% on the comparison period. The result before taxes was EUR 6.0 million (MEUR 4.1).- Undiluted earnings per share were EUR 1.09 (EUR 0.69) and diluted earnings per share were EUR 1.08 (EUR 0.69).- Net sales for the second quarter were EUR 43.7 million and

Changes in the number of shares and share capital

At the beginning of July 2018, the total number of shares in Micro Systemation AB (Publ) (”MSAB”) was 19,082,000, of which 1,000,000 were A-shares, 17,460,000 were B-shares, and 622,000 were C-shares. Share capital was SEK 3,816,400.  At the Annual General Meeting on May 6 2015, a long-term incentive program was approved, which has been partly exercised during the month of July 2018. Stock options have been converted into 30,000 B-shares, meaning an increase of share capital of 6,000 SEK.    At the end of July 2018, the total number of shares is 19,112,00, of which 1,000,000 are A-

Redeye: Mr Green - Continued strong growth expected

MRG’s report for Q2 was almost spot-on our income projections but with better than expected profitability. We believe the company continues to focus on value-adding initiatives; new growth ventures, smart acquisitions, digital marketing improvements and more. Read more and download the research update: http://bit.ly/2M4XRjq Start following companies at Redeye to receive the latest equity research within Life Science and Technology. This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/about/

Change in number of shares and votes in Sweco AB (publ)

At requests of shareholders, the Swedish Companies Registration Office has registered that 12,837 class A shares have been converted to class B shares during July 2018 with the support of the conversion clause in the Articles of Association.  After the registration, as per 31 July 2018, the total number of shares in Sweco amounts to 121,083,819, of which 10,469,653 are of class A, 110,614,166 are of class B representing 21,531,069.6, votes in the company. The share capital amounts to 121,083,819 SEK. On the date and time of publication of this information, Sweco holds 2 662 262 class

Read original

Axactor acquires an unsecured NPL Portfolio in Spain

Madrid, 31st July 2018 Axactor has managed to close with Sareb the purchase of the "Navia" project, an unsecured portfolio with an outstanding balance of approximately EUR 2.3 billion and with close to four thousand cases. This portfolio is by volume the largest acquisition that Axactor has made in Spain, but with a relatively low Capex investment of below EUR 10 million. Including this portfolio, Axactor Spain will manage purchased debt of more than EUR 5 billion in face value. Axactor continues to grow in the Spanish NPL sector, diversifying investments in all NPLs segments, both

Allgon AB (publ) publish prospectus and have applied for listing of bond loan on Nasdaq Stockholm’s Corporate Bond List

The board of directors of Allgon AB (publ) (”Allgon” or the ”Company”) have in connection with the application for admission to trading of a 2018/2022 bond loan of SEK 276 million, which was announced 31 May 2018 (the “Bond Loan”), prepared a prospectus (the “Prospectus”). The Prospectus has today been approved by, and registered with, the Swedish Financial Supervisory Authority (the “SFSA”) and the Prospectus is available on the Company’s website. The Company have applied to list the Bond Loan on Nasdaq Stockholm’s Corporate Bond List.The Prospectus have been approved by and registered

Studsvik's chief financial officer Pål Jarness to leave the company in February 2019

By mutual agreement Pål Jarness will leave Studsvik at the end of February 2019. The work of recruiting a successor has been started. “Since 2013 Pål has been a driving force in Studsvik's extensive restructuring and streamlining of its business. In the autumn he will continue in his role as CFO to join with the Executive Group Management in building a business-oriented operation,” says Camilla Hoflund, President and CEO of Studsvik AB. For more information, please contact: Camilla Hoflund, +46 760 02 10 66 Facts about Studsvik Studsvik offers a range of advanced technical

Orkla ASA: Trade subject to notification - treasury shares

Orkla ASA has on 30 July 2018 bought 248,000 Orkla shares through broker at an average price of NOK 69.32 per share. Orkla's total holding of treasury shares after this transaction is 13,020,259 shares. Orkla ASAOslo, 30 July 2018Ref.:Senior Vice President Group TreasuryGeir SolliTel.: +47 9954 2789 This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

There are no items matching the current filter
There are no more items matching the current filter
Back to top